Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
628 studies found for:    "ulcerative colitis"
Show Display Options
Rank Status Study
1 Unknown  Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Conditions: Ulcerative Colitis;   Left-sided Ulcerative Colitis;   Distal Ulcerative Colitis
Interventions: Drug: Zoenasa-1:4;   Drug: Mesalamine Enema
2 Recruiting TD-1473 for Active Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Drug: TD-1473;   Drug: Placebo
3 Recruiting Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Biological: Bertilimumab;   Biological: Placebo
4 Unknown  Melatonin & Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Melatonin;   Other: Placebo
5 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
6 Completed Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol (mesalamine)
7 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
8 Withdrawn Vitamin D Treatment in Ulcerative Colitis
Conditions: Ulcerative Colitis;   Inflammatory Bowel Disease
Interventions: Drug: Vitamin D3;   Other: Placebo
9 Completed Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Mesalamin
10 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
11 Completed Ulcerative Colitis Relapse Prevention Trial, Hypnosis
Conditions: Ulcerative Colitis;   Inflammatory Bowel Disease
Interventions: Behavioral: Hypnotherapy;   Behavioral: Standard care;   Behavioral: Mind Body Therapy
12 Completed Chromoendoscopy for Ulcerative Colitis Surveillance
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention: Procedure: Chromoendoscopy with magnification
13 Unknown  Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention:
14 Terminated An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Visilizumab (Nuvion®; HuM291)
15 Terminated Basiliximab Maintenance in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
16 Active, not recruiting Special Investigation in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
17 Terminated Endomicroscopy in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Device: PENTAX EC-3870CIFK / EC-3870CILK confocal colonoscopes
18 Recruiting Low Dose IL-2 for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Interleukin-2 (aldesleukin).
19 Terminated Effects of Probiotics in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Kyo-Dophilus;   Dietary Supplement: placebo
20 Unknown  Oral OKT3 for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Oral OKT3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years